Article
Belzutifan approved in EU for renal cell carcinoma
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Adding cabozantinib to nivolumab/ipilimumab confers PFS benefit in aRCC
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Anktiva under review in UK for BCG-unresponsive NMIBC with CIS
Disitamab vedotin plus toripalimab shows safety, efficacy in MIBC